| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $57.3M | +15.8% |
| SG&A Expense | $27.3M | -18.8% |
| Operating Income | -$84.5M | -1.8% |
| Pre-tax Income | -$81.1M | +0.5% |
| Income Tax | $27K | +1450.0% |
| Net Income | -$81.2M | +0.5% |
| EPS (Basic) | -$53.08 | +76.7% |
| EPS (Diluted) | -$53.08 | +76.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $166.2M | +219.8% |
| Short-term Investments | $0 | -100.0% |
| Current Assets | $172.7M | +97.4% |
| Total Assets | $221.7M | +82.8% |
| Current Liabilities | $19.5M | -7.3% |
| Total Liabilities | $51.8M | -0.6% |
| Stockholders' Equity | $169.9M | +145.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$67.3M | -15.5% |
| Capital Expenditures | $7.8M | — |
| Investing Cash Flow | $11.2M | -64.1% |
| Financing Cash Flow | $187.8M | — |
| Free Cash Flow | -$75.1M | -29.0% |